Haemonetics (HAE) Stock Forecast for 2024–2028. Sell or Buy Prediction







Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …

Haemonetics (HAE) Stock Forecast for 2024–2028. Sell or Buy?

Updated: April 18, 2024 (11:49)

Sector: Healthcare

The share price of Haemonetics Corporation (HAE) now

Latest session on the 18th of April for
Haemonetics Corporation is negative
Trading Volume: 966333
Open: 84.86 /  High: 86.14 /  Low: 82.9
What analysts predict: $105.57
52-week High/Low: $95.26 / $70.74

50/200 Day Moving Average: $78.3 / $84.83

This figure corresponds to the Average Price over the previous 50/200 days. For Haemonetics stocks, the 50-day moving average is the support level today.

For Haemonetics stocks, the 200-day moving average is the support level today.

Are you interested in Haemonetics Corporation stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Haemonetics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Haemonetics share be worth in 2024 - 2028?

When should I take profit in Haemonetics stock? When should I record a loss on Haemonetics stock? What are analysts' forecasts for Haemonetics stock? What is the future of Haemonetics stock? We forecast Haemonetics stock performance using neural networks based on historical data on Haemonetics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Haemonetics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Haemonetics shares. This happens once a day.


Historical and forecast chart of Haemonetics stock

The chart below shows the historical price of Haemonetics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Haemonetics stock price can be found in the table below.

Long-term forecasts by years.

Haemonetics Corporation is a medical company offering hematology products and solutions. It operates through three segments: Plasma, Blood Center and Hospital. The company offers automated plasma collection devices, related disposable products and software, including NexSys PCS and PCS2 plasmapheresis equipment, as well as related disposable and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations and supply chain; and the NexLynk DMS Donor Management System.

Haemonetics daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 20 84.34 83.26 85.49 2.67
Apr 21 83.16 82.22 84.80 3.14
Apr 22 84.25 83.59 85.45 2.22
Apr 23 84.59 83.19 85.55 2.83
Apr 24 86.70 85.14 87.48 2.75
Apr 25 88.84 87.09 89.46 2.72
Apr 26 89.87 88.20 91.69 3.96
Apr 27 89.95 89.03 90.81 1.99
Apr 28 89.53 88.98 90.59 1.81
Apr 29 87.87 86.90 89.75 3.28
Apr 30 86.42 85.91 88.17 2.63
May 01 88.82 87.35 90.75 3.89
May 02 87.74 86.93 88.78 2.14
May 03 89.11 88.44 90.79 2.66
May 04 87.92 86.47 89.30 3.27
May 05 88.64 87.10 90.46 3.87
May 06 87.66 87.10 88.45 1.55
May 07 87.69 86.06 89.29 3.75
May 08 85.40 84.73 86.84 2.48
May 09 84.33 83.65 84.92 1.52
May 10 83.40 81.95 84.06 2.57
May 11 81.95 80.34 82.57 2.78
May 12 83.64 82.84 84.90 2.49
May 13 83.28 81.54 84.32 3.41
May 14 82.60 81.14 83.15 2.48
May 15 82.60 81.09 83.70 3.22
May 16 82.48 81.86 83.56 2.07
May 17 82.74 81.42 84.23 3.45
May 18 82.94 81.69 84.26 3.15
May 19 81.01 80.19 82.19 2.49

Haemonetics Daily Price Targets


Haemonetics Stock Forecast 04-20-2024.

Forecast target price for 04-20-2024: $84.34.
Negative dynamics for Haemonetics shares will prevail with possible volatility of 2.603%.
Pessimistic target level: 83.26
Optimistic target level: 85.49

Haemonetics Stock Forecast 04-21-2024.

Forecast target price for 04-21-2024: $83.16.
Negative dynamics for Haemonetics shares will prevail with possible volatility of 3.043%.
Pessimistic target level: 82.22
Optimistic target level: 84.80

Haemonetics Stock Forecast 04-22-2024.

Forecast target price for 04-22-2024: $84.25.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.173%.
Pessimistic target level: 83.59
Optimistic target level: 85.45

Haemonetics Stock Forecast 04-23-2024.

Forecast target price for 04-23-2024: $84.59.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.753%.
Pessimistic target level: 83.19
Optimistic target level: 85.55

Haemonetics Stock Forecast 04-24-2024.

Forecast target price for 04-24-2024: $86.70.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.673%.
Pessimistic target level: 85.14
Optimistic target level: 87.48

Haemonetics Stock Forecast 04-25-2024.

Forecast target price for 04-25-2024: $88.84.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.650%.
Pessimistic target level: 87.09
Optimistic target level: 89.46

HAE (HAE) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
May. 86.86 82.61 93.81 11.94
Jun. 82.95 77.15 89.59 13.89
Jul. 84.36 78.12 89.93 13.13
Aug. 84.28 79.31 86.72 8.55
Sep. 77.37 73.11 79.46 7.98
Oct. 76.29 71.79 79.19 9.34
Nov. 76.44 73.84 78.73 6.21
Dec. 76.13 71.18 79.48 10.44

Haemonetics forecast for this year


Haemonetics Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $86.8634. Pessimistic: $82.61. Optimistic: $93.81


Haemonetics Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $82.9546. Pessimistic: $77.15. Optimistic: $89.59


Haemonetics Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $84.3648. Pessimistic: $78.12. Optimistic: $89.93


Haemonetics Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $84.2804. Pessimistic: $79.31. Optimistic: $86.72


Haemonetics Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $77.3695. Pessimistic: $73.11. Optimistic: $79.46


Haemonetics Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $76.2863. Pessimistic: $71.79. Optimistic: $79.19


Haemonetics Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $76.4389. Pessimistic: $73.84. Optimistic: $78.73


Haemonetics Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $76.1331. Pessimistic: $71.18. Optimistic: $79.48



Haemonetics (HAE) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 72.78 68.49 76.06 9.95
Feb 78.53 74.21 83.56 11.18
Mar 74.29 70.13 79.42 11.69
Apr 72.21 68.60 74.81 8.30
May 76.98 75.28 80.37 6.32
Jun 81.75 80.03 86.90 7.90
Jul 83.30 78.56 86.55 9.24
Aug 84.89 80.05 89.64 10.70
Sep 83.44 77.77 85.70 9.25
Oct 88.87 81.76 92.33 11.45
Nov 93.22 89.77 95.18 5.68
Dec 90.43 85.81 93.50 8.22

Haemonetics (HAE) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 84.10 81.74 88.89 8.04
Feb 80.65 78.31 83.55 6.27
Mar 80.57 78.07 84.84 7.98
Apr 81.61 79.41 87.98 9.74
May 80.72 76.36 86.61 11.84
Jun 81.52 76.80 83.15 7.65
Jul 86.01 79.21 87.90 9.88
Aug 80.93 74.70 85.79 12.92
Sep 82.88 76.91 86.69 11.28
Oct 85.20 78.47 90.73 13.52
Nov 82.81 76.35 84.80 9.96
Dec 87.70 84.71 90.33 6.21

Haemonetics (HAE) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 91.03 85.02 95.58 11.05
Feb 95.85 93.27 99.50 6.26
Mar 92.21 86.31 94.79 8.95
Apr 95.35 92.77 97.63 4.98
May 103.17 96.67 106.05 8.85
Jun 98.11 95.36 100.07 4.71
Jul 102.03 95.81 109.99 12.89
Aug 94.48 89.85 98.17 8.47
Sep 94.20 87.04 99.19 12.25
Oct 89.49 87.43 94.95 7.92
Nov 92.26 86.08 95.40 9.77
Dec 99.18 91.55 103.65 11.67

Haemonetics (HAE) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 102.16 95.52 104.20 8.33
Feb 112.38 105.52 115.41 8.57
Mar 112.49 109.23 121.15 9.84
Apr 107.54 104.21 114.85 9.27
May 115.60 112.25 120.34 6.72
Jun 116.30 111.88 122.69 8.82
Jul 115.60 112.83 122.88 8.18
Aug 109.70 104.88 112.01 6.37
Sep 111.57 108.22 118.82 8.92
Oct 116.92 113.88 123.71 7.94
Nov 106.87 103.24 113.71 9.21
Dec 105.69 97.66 110.13 11.32

Haemonetics information and performance

Haemonetics Address

125 SUMMER STREET, BOSTON, MA, US

Market Capitalization: 4 310 724 000 $

Market capitalization of the Haemonetics Corporation is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of HAE shares in the company outstanding by the market price of one share.

EBITDA: 293 089 000 $

EBITDA of Haemonetics is earnings before interest, income tax and depreciation of assets.

PE Ratio: 34.5

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.633

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.46

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.047
Quarterly Revenue Growth YOY: 0.101
Trailing PE: 34.5

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 19.61

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.94

Enterprise Value (EV) /Revenue

EV To EBITDA: 18.98

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 50786000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.